A new U.S. customs rule could make it substantially harder for Americans to receive Canadian prescription drugs by mail, with stricter entry requirements scheduled to apply to many international postal shipments on October 22, 2026.
The change does not specifically name Canada or create an explicit blanket ban on Canadian medicines.
Instead, it removes the administrative de minimis exemption for low-value goods entering the United States through the international postal network and replaces it with a more detailed postal entry process.
For Americans who rely on Canadian pharmacies because medicines can cost less than they do in the United States, the practical effect could be higher costs, additional delays or a loss of access if pharmacies and postal carriers cannot meet the new requirements.
Table of Contents
Canadian Prescription Drugs: What the new customs rule changes
U.S. Customs and Border Protection published the interim final rule on June 24, 2026.
It suspends the administrative exemption that previously applied to imports valued at $800 or less arriving through the international postal system.
The rule establishes a new postal informal entry process for qualifying shipments valued at up to $2,500.
Filers must provide more detailed information, including the applicable tariff classification, shipment description and other entry data.
CBP also requires the filer to have the legal authority to make the entry, which can include a licensed customs broker.
The agency said the new system is intended to improve duty collection, prevent unlawful imports and bring postal shipments closer to the rules already applied to other informal entries.
The rule took effect in stages.
The broader postal process became effective on July 24, 2026, while specific compliance requirements for certain data submissions are scheduled for October 22, 2026.
Why Canadian pharmacies are affected
Canadian pharmacies have long been a source of lower-cost medicines for some U.S. consumers, although importing prescription drugs for personal use into the United States is subject to federal restrictions and Food and Drug Administration requirements.
The customs changes apply to international mail rather than only to Canadian shipments.
However, Canada is a major source of cross-border prescription orders, making Canadian pharmacies particularly exposed to the new filing and processing rules.
Industry representatives say many mail-order prescription shipments may not be able to move through the new process without a broker, additional documentation or payment of duties and fees.
That could make small individual orders commercially impractical, even where the medicine itself is not prohibited.
The Canadian International Pharmacy Association has warned that the October 22 compliance date could interrupt many prescription shipments from Canada and other countries.
That assessment reflects the likely operational impact of the rule, rather than a formal U.S. announcement that all Canadian prescription imports are banned.
What happens to prescription medicines at the border
Prescription drugs face additional controls beyond ordinary customs procedures.
The FDA generally restricts the importation of medicines that are not approved, labelled or prescribed in accordance with U.S. requirements, although limited enforcement discretion and specific importation programs exist.
The FDA has authorized certain state-based programs to import eligible prescription drugs from Canada under Section 804 of the Federal Food, Drug and Cosmetic Act.
Those programs are different from an individual ordering a personal supply from a Canadian pharmacy by mail.
CBP guidance says travellers entering the United States should declare medications, keep them in their original packaging and generally carry no more than a 90-day supply.
The new postal requirements should not be confused with ordinary travel rules for a person carrying medication for their own use.
What Canadian consumers need to know
The rule is primarily expected to affect U.S. residents receiving medicine from abroad.
It does not, by itself, change the Canadian rules governing prescriptions dispensed by licensed Canadian pharmacies or medicines carried by Canadian residents for their own treatment.
Health Canada says Canadian residents are generally not allowed to bring prescription drugs into Canada for other people, whether by mail, courier or personal transport.
Limited exceptions can apply, including certain personal quantities for Canadians returning with medication prescribed and filled for their own use.
Canadians travelling to the United States should continue to carry medication in its original packaging, bring documentation where appropriate and verify the latest requirements before crossing the border.
What happens next
CBP is continuing to refine the postal entry system.
A proposed rule published on October 8, 2026, would further revise the process and require additional electronic entry information and bond-related procedures for certain informal mail shipments.
That proposal indicates the system is still evolving.
Pharmacies, carriers and customers may see additional guidance before the October 22 compliance date, but there is no guarantee that the deadline will be delayed or that prescription shipments will receive a broad exemption.
Americans who depend on medicine ordered from Canada should speak with their physician and pharmacist about lawful alternatives, including domestic supply, insurance coverage, authorized importation programs or an adequate refill plan.
They should not assume that placing an order before October 22 guarantees delivery, because customs clearance depends on the shipment, the carrier and the applicable FDA and CBP rules.
Frequently Asked Questions
Are Canadian prescription drugs being banned in the United States?
No blanket ban has been announced. The new rule removes the low-value postal exemption and adds filing, classification and processing requirements that could make many shipments difficult or more expensive.
When do the new U.S. customs requirements take effect?
The new postal entry process took effect on July 24, 2026, while specific compliance requirements for certain shipments are scheduled for October 22, 2026.
Does the rule apply only to medicines from Canada?
No. The rule applies broadly to qualifying goods arriving through the international postal network from countries around the world, but Canadian pharmacies are among the businesses likely to be affected.
Can Canadians still travel to the United States with their own medication?
Travel rules are different from postal-import rules. Medication should be declared, kept in its original packaging and carried in a reasonable personal quantity, generally no more than a 90-day supply.
What should Americans who rely on Canadian pharmacies do?
They should speak with their doctor and pharmacist about lawful alternatives, refill timing, insurance coverage and whether an authorized importation program applies to their medication.
Fact-Checked: Key dates, customs requirements and prescription-import guidance were checked against U.S. Customs and Border Protection, the Federal Register, the FDA and Health Canada.
Disclaimer: Prescription and importation rules can vary by medication and circumstance, so readers should confirm their situation with a licensed pharmacist, physician or customs authority.